Brief: Abvc Collaboration With Oncox Biopharma, Abvc Expecting Aggregate Income Of $13.75 Million And Royalties Of Up To $12.50 Million

ABVC Biopharma

09/05/2024 16:09

May 9 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA INC - COLLABORATION BETWEEN ABVC AND ONCOX
BIOPHARMA, ABVC EXPECTING AGGREGATE INCOME OF $13.75 MILLION AND
ROYALTIES OF UP TO $12.50 MILLION
    * ABVC BIOPHARMA- GRANTS ONCOX EXCLUSIVE RIGHTS FOR ONE OF
ABVC’S
FOUR PRODUCTS IN ITS ONCOLOGY PIPELINE TO DEVELOP, MANUFACTURE,
COMMERCIALIZE BLEX 404

Source text for Eikon:  ID:n0001213900-24-041053 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com;))